These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11341944)

  • 1. PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactions.
    Prusis P; Muceniece R; Andersson P; Post C; Lundstedt T; Wikberg JE
    Biochim Biophys Acta; 2001 Jan; 1544(1-2):350-7. PubMed ID: 11341944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of regions in the MC1 receptor of importance for the selectivity of the MC1 receptor super-selective MS04/MS05 peptides.
    Muceniece R; Mutule I; Mutulis F; Prusis P; Szardenings M; Wikberg JE
    Biochim Biophys Acta; 2001 Jan; 1544(1-2):278-82. PubMed ID: 11341936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric melanocortin MC1 and MC3 receptors: identification of domains participating in binding of melanocyte-stimulating hormone peptides.
    Schiöth HB; Yook P; Muceniece R; Wikberg JE; Szardenings M
    Mol Pharmacol; 1998 Jul; 54(1):154-61. PubMed ID: 9658201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteo-chemometrics analysis of MSH peptide binding to melanocortin receptors.
    Prusis P; Lundstedt T; Wikberg JE
    Protein Eng; 2002 Apr; 15(4):305-11. PubMed ID: 11983931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and biological activity of C-terminally modified melanocortin peptides: a comparison between their actions at rodent MC1 and MC3 receptors.
    Peng PJ; Sahm UG; Doherty RV; Kinsman RG; Moss SH; Pouton CW
    Peptides; 1997; 18(7):1001-8. PubMed ID: 9357058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of melanocortin receptor subtypes by radioligand binding analysis.
    Schiöth HB; Muceniece R; Wikberg JE; Chhajlani V
    Eur J Pharmacol; 1995 Feb; 288(3):311-7. PubMed ID: 7774675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes.
    Schiöth HB; Muceniece R; Larsson M; Mutulis F; Szardenings M; Prusis P; Lindeberg G; Wikberg JE
    Eur J Pharmacol; 1997 Jan; 319(2-3):369-73. PubMed ID: 9042613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors.
    Oosterom J; Nijenhuis WA; Schaaper WM; Slootstra J; Meloen RH; Gispen WH; Burbach JP; Adan RA
    J Biol Chem; 1999 Jun; 274(24):16853-60. PubMed ID: 10358030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide.
    Prusis P; Schiöth HB; Muceniece R; Herzyk P; Afshar M; Hubbard RE; Wikberg JE
    J Mol Graph Model; 1997 Oct; 15(5):307-17, 334. PubMed ID: 9640562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel melanocortin4 receptor selective MSH analogues.
    Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
    Br J Pharmacol; 1998 May; 124(1):75-82. PubMed ID: 9630346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three dimensional model for the interaction of MSH with the melanocortin-1 receptor.
    Prusis P; Frändberg PA; Muceniece R; Kalvinsh I; Wikberg JE
    Biochem Biophys Res Commun; 1995 May; 210(1):205-10. PubMed ID: 7741742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteochemometric modeling reveals the interaction site for Trp9 modified alpha-MSH peptides in melanocortin receptors.
    Lapinsh M; Prusis P; Petrovska R; Uhlén S; Mutule I; Veiksina S; Wikberg JE
    Proteins; 2007 May; 67(3):653-60. PubMed ID: 17357163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocortin receptors: ligands and proteochemometrics modeling.
    Wikberg JE; Mutulis F; Mutule I; Veiksina S; Lapinsh M; Petrovska R; Prusis P
    Ann N Y Acad Sci; 2003 Jun; 994():21-6. PubMed ID: 12851294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes.
    Schiöth HB; Müceniece R; Mutulis F; Prusis P; Lindeberg G; Sharma SD; Hruby VJ; Wikberg JE
    Peptides; 1997; 18(7):1009-13. PubMed ID: 9357059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype selective binding properties of substituted linear melanocyte stimulating hormone analogues.
    Schiöth HB; Tesfaye A; Mutulis F; Rudzish R; Mutule I; Muceniece R; Watanobe H; Wikberg JE
    Neuropeptides; 2002 Dec; 36(6):427-34. PubMed ID: 12507437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes.
    Lapinsh M; Veiksina S; Uhlén S; Petrovska R; Mutule I; Mutulis F; Yahorava S; Prusis P; Wikberg JE
    Mol Pharmacol; 2005 Jan; 67(1):50-9. PubMed ID: 15470082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonist.
    Han G; Quillan JM; Carlson K; Sadée W; Hruby VJ
    J Med Chem; 2003 Feb; 46(5):810-9. PubMed ID: 12593660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the stereostructural requirements of peptide ligands for the melanocortin receptors.
    Hruby VJ; Cai M; Grieco P; Han G; Kavarana M; Trivedi D
    Ann N Y Acad Sci; 2003 Jun; 994():12-20. PubMed ID: 12851293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.